查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1726346

全球自擴增 RNA 合成市場：市場規模、佔有率、趨勢分析（按產品/服務、應用、最終用途和地區）、細分市場預測（2025-2030 年）

Self-amplifying RNA Synthesis Market Size, Share & Trends Analysis Report By Product & Service, By Application By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

自擴增 RNA 合成市場的成長與趨勢：

預計到 2030 年，全球自擴增 RNA 合成市場規模將達到 3.108 億美元，2025 年至 2030 年的複合年成長率為 19.24%。

這種擴張主要是由於對基於 RNA 的疫苗和療法的需求不斷成長，尤其是在 COVID-19 大流行期間。由於其能夠誘導更強的免疫反應，研究人員正在將 saRNA 視為快速開發疫苗的有希望的平台。 RNA 的自我擴增能力允許使用較低劑量，可能產生較少的副作用，因此在臨床試驗中獲得支持。因此，製藥公司正專注於將 saRNA 納入其產品平臺，進一步推動市場成長。

人們對個人化醫療的興趣日益濃厚也是推動市場擴張的關鍵因素。隨著基因組技術的進步，針對特定基因特徵的個人化治療的需求日益成長。自擴增 RNA 技術使得開發針對個別患者的疫苗和基因療法成為可能。此外，隨著醫療保健系統轉向更個人化的治療，對 saRNA 等創新解決方案的需求將持續成長。

此外，全球感染疾病的增加和對新治療方案的迫切需求為 saRNA 技術創造了有利的環境。除了疫苗之外，自擴增 RNA 也被用於治療多種疾病，包括癌症、遺傳疾病和自體免疫疾病。 saRNA 可用於多種應用，提供廣泛的治療選擇，並吸引公共和私營部門的大量投資。此外，RNA 技術的不斷進步和臨床試驗的增加預計將加速市場採用。人們對此類多疾病應用的興趣日益濃厚，確保了未來幾年全球自擴增 RNA 合成市場的光明前景。

自擴增 RNA 合成市場：分析概述

  • 根據產品/服務提供，客製化合成服務部門預計將在預測期內見證最快的成長率，這歸因於對客製化 RNA 解決方案的需求不斷增加，這對於個人化藥物和基於 RNA 的治療方法的開發至關重要。
  • 根據應用，治療藥物開發領域預計將佔據市場主導地位，收益佔有率。
  • 根據最終用途，製藥和生物技術公司部門在 2024 年佔據了最大的收益佔有率。這些公司負責 RNA 療法研究、產品開發和大規模製造，對 RNA 合成服務產生了巨大的需求。他們的大量投資，尤其是在疫苗製造和基因治療的 RNA 技術方面的投資，使他們成為市場的主要參與者。隨著越來越多的基於 RNA 的治療方法（包括新型疫苗和基因療法）投入開發，這些公司繼續成為 RNA 合成解決方案的主要最終用戶。
  • 按地區分類，北美在 2024 年佔據自擴增 RNA 合成市場的最大收入佔有率。美國繼續引領 RNA 技術研究，並在基於 RNA 的療法和疫苗的開發方面投入大量資金。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 自擴增 RNA 合成市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 自擴增 RNA 合成市場：分析工具
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章 自擴增 RNA 合成市場：按產品和服務進行的估計和趨勢分析

  • 產品/服務儀表板
  • 全球自擴增 RNA 合成市場（依產品與服務）的波動
  • 全球自擴增 RNA 合成市場：按產品和服務分類的市場規模和趨勢分析（2018-2030 年）
  • 產品
    • 產品：市場規模預測與趨勢分析（2018-2030年）
    • 預製saRNA
    • 酵素和試劑
    • 其他
  • 客製化合成服務
    • 客製化合成服務：市場規模預測與趨勢分析（2018-2030）

第5章 自擴增 RNA 合成市場：按應用進行的估計和趨勢分析

  • 特定於應用程式的儀表板
  • 全球自擴增RNA合成市場波動分析（依應用）
  • 全球自擴增 RNA 合成市場：市場規模與趨勢分析（按應用分類）（2018-2030 年）
  • 藥物開發
    • 治療藥物開發：市場規模預測與趨勢分析（2018-2030）
    • 感染疾病
    • 瘤
    • 其他
  • 生物醫學研究
    • 生物醫學研究：市場規模預測與趨勢分析（2018-2030）

第6章 自擴增 RNA 合成市場：依最終用途的估計與趨勢分析

  • 最終用途儀表板
  • 全球自擴增 RNA 合成市場趨勢分析（依最終用途）
  • 全球自擴增 RNA 合成市場：依最終用途分類的市場規模與趨勢分析（2018-2030 年）
  • 製藥和生物技術公司
    • 製藥和生物技術公司：市場規模預測和趨勢分析（2018-2030）
  • 學術研究所
    • 學術研究機構：市場規模預測與趨勢分析（2018-2030）
  • 其他最終用途
    • 其他最終用途：市場規模預測與趨勢分析（2018-2030）

第7章 自擴增 RNA 合成市場：按地區估計和趨勢分析

  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 區域市場儀表板
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 參與企業
  • 企業市場分析（2024年）
  • 戰略地圖
  • 參與企業概況
    • 金斯瑞
    • 創新百健
    • OZ 生物科學
    • 中銀科學
    • 科洛伊斯生物科學有限公司
    • 創新生物實驗室
    • 馬拉威生命科學
    • Areterna有限責任公司
    • 應用DNA科學（LineaRx）
Product Code: GVR-4-68040-557-8

Self-amplifying RNA Synthesis Market Growth & Trends:

The global self-amplifying RNA synthesis market size is expected to reach USD 310.8 million by 2030 and is anticipated to grow at a CAGR of 19.24% from 2025 to 2030. This expansion is largely driven by the increasing demand for RNA-based vaccines and therapies, particularly during the COVID-19 pandemic. Researchers are turning to saRNA as a promising platform for rapid vaccine development due to its ability to induce a stronger immune response. The self-amplification feature of RNA allows for lower dosages and potentially fewer side effects, which is gaining traction in clinical trials. As a result, pharmaceutical companies are focusing on incorporating saRNA into their product pipelines, further boosting market growth.

The growing interest in personalized medicine is another key factor contributing to the market's expansion. With advancements in genomic technologies, there is an increasing need for tailored treatments targeting specific genetic profiles. Self-amplifying RNA technologies enable the development of vaccines and gene therapies that can be customized for individual patients. Furthermore, as healthcare systems shift toward more personalized care, the demand for innovative solutions such as saRNA will continue to rise.

In addition, the global rise in infectious diseases and the urgent need for new therapeutic options create a favorable environment for saRNA technologies. Beyond vaccines, self-amplifying RNA is being explored for various diseases, including cancer, genetic disorders, and autoimmune diseases. The ability of saRNA to be engineered for different applications allows for diverse therapeutic options, attracting substantial investment from the public and private sectors. Moreover, the ongoing advancements in RNA technology and the increasing number of clinical trials are expected to accelerate market adoption. This growing interest in multi-disease applications ensures a promising outlook for the global self-amplifying RNA synthesis market in the coming years.

Self-amplifying RNA Synthesis Market Report Highlights:

  • Based on product & service, the custom synthesis services segment is expected to witness the fastest growth rate during the forecast period, due to the increasing demand for tailored RNA solutions, which are essential in the development of personalized medicines and RNA-based therapeutics.
  • Based on an application, the therapeutics development segment dominated the market and accounted for the largest revenue share in 2024, driven by the surge in research and development of RNA-based therapeutics, such as vaccines and gene-editing tools, which have significantly contributed to the growth of this segment.
  • Based on end use, the pharmaceutical & biotechnology companies segment held the largest revenue share in 2024. These companies are in charge of RNA therapeutic research, product development, and large-scale production, thus creating a substantial demand for RNA synthesis services. Their significant investments in RNA technology, particularly for vaccine production and genetic therapies, have positioned them as major players in the market. The growing number of RNA-based therapies in development, including novel vaccines and gene therapies, ensures that these companies remain the primary end-users of RNA synthesis solutions.
  • Based on region, North America held the largest revenue share in 2024 in the self-amplifying RNA synthesis market, primarily driven by the region's strong pharmaceutical and biotechnology industries. The U.S. continues to lead RNA technology research, with significant investments in RNA-based therapeutics and vaccine development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Self-Amplifying RNA Synthesis Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in RNA Technology
      • 3.2.1.2. Rising Demand for Personalized Medicine
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Manufacturing and Scalability Challenges
      • 3.2.2.2. Regulatory and Scientific Hurdles
  • 3.3. Self-Amplifying RNA Synthesis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Self-Amplifying RNA Synthesis Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global Self-Amplifying RNA Synthesis Market Product & Service Movement Analysis
  • 4.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.2. Premade saRNA
      • 4.4.2.1. Premade saRNA Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.3. Enzymes & Reagents
      • 4.4.3.1. Enzymes & Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5. Custom Synthesis Services
    • 4.5.1. Custom Synthesis Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. Self-Amplifying RNA Synthesis Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Self-Amplifying RNA Synthesis Market Application Movement Analysis
  • 5.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Therapeutics Development
    • 5.4.1. Therapeutics Development Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.4.2. Infectious Diseases
      • 5.4.2.1. Infectious Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.4.3. Oncology
      • 5.4.3.1. Oncology Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5. Biomedical Research
    • 5.5.1. Biomedical Research Techniques Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. Self-Amplifying RNA Synthesis Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Self-Amplifying RNA Synthesis Market End Use Movement Analysis
  • 6.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 6.6. Other End Use
    • 6.6.1. Other End Use Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 7. Self-Amplifying RNA Synthesis Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Strategy Mapping
  • 8.4. Participants Overview
    • 8.4.1. GenScript
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product & Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Creative Biogene
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product & Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. OZ Biosciences
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product & Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. BOC Sciences
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product & Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Croyez Bioscience Co., Ltd.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product & Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Creative Biolabs
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product & Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Maravai LifeSciences
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product & Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Areterna LLC
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product & Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Applied DNA Sciences, Inc. (LineaRx)
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product & Service benchmarking
      • 8.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 3 North America Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 4 North America Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 North America Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 7 U.S. Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9 Canada Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 10 Canada Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 Canada Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 13 Mexico Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 Mexico Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 Europe Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 16 Europe Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 17 Europe Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 18 Europe Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 20 UK Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 21 UK Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 22 Germany Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 23 Germany Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Italy Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 26 Italy Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 Italy Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 28 France Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 29 France Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 France Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Spain Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 32 Spain Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Spain Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 35 Sweden Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Sweden Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Denmark Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 38 Denmark Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 Norway Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 41 Norway Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 42 Norway Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 China Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 48 China Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 China Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Japan Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 51 Japan Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 India Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 54 India Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 India Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 57 South Korea Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 59 Australia Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 60 Australia Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Australia Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 63 Thailand Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 66 Latin America Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 67 Latin America Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Latin America Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Brazil Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 70 Brazil Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Brazil Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 73 Argentina Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Argentina Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 Middle East Africa Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 76 Middle East Africa Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 77 Middle East Africa Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 Middle East Africa Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 80 South Africa Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 85 UAE Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 86 UAE Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 UAE Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling for Market Share Assessment
  • Fig. 7 Market formulation & Validation
  • Fig. 8 Self-Amplifying RNA Synthesis Market: Market Outlook
  • Fig. 9 Parent Market Outlook
  • Fig. 10 Related/Ancillary Market Outlook
  • Fig. 11 Penetration and Growth Prospect Mapping
  • Fig. 12 Industry Value Chain Analysis
  • Fig. 13 Self-Amplifying RNA Synthesis Market Driver Impact
  • Fig. 14 Self-Amplifying RNA Synthesis Market Restraint Impact
  • Fig. 15 Self-Amplifying RNA Synthesis Market Strategic Initiatives Analysis
  • Fig. 16 Self-Amplifying RNA Synthesis Market: Product & Service Movement Analysis
  • Fig. 17 Self-Amplifying RNA Synthesis Market: Product & Service Outlook and Key Takeaways
  • Fig. 18 Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Premade saRNA Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Enzymes & Reagents Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Custom Synthesis Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Self-Amplifying RNA Synthesis Market: Application Movement Analysis
  • Fig. 24 Self-Amplifying RNA Synthesis Market: Application Outlook and Key Takeaways
  • Fig. 25 Therapeutics Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Biomedical Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Self-Amplifying RNA Synthesis Market: End-Use Movement Analysis
  • Fig. 31 Self-Amplifying RNA Synthesis Market: End-Use Outlook and Key Takeaways
  • Fig. 32 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Other End Use Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Global Self-Amplifying RNA Synthesis Market: Regional Movement Analysis
  • Fig. 36 Global Self-Amplifying RNA Synthesis Market: Regional Outlook and Key Takeaways
  • Fig. 37 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Country Dynamics
  • Fig. 39 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Country Dynamics
  • Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Country Dynamics
  • Fig. 43 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK Country Dynamics
  • Fig. 46 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Country Dynamics
  • Fig. 48 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France Country Dynamics
  • Fig. 50 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy Country Dynamics
  • Fig. 52 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Country Dynamics
  • Fig. 54 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark Country Dynamics
  • Fig. 56 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden Country Dynamics
  • Fig. 58 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Norway Country Dynamics
  • Fig. 60 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 China Country Dynamics
  • Fig. 63 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Japan Country Dynamics
  • Fig. 65 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 India Country Dynamics
  • Fig. 67 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand Country Dynamics
  • Fig. 69 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea Country Dynamics
  • Fig. 71 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Australia Country Dynamics
  • Fig. 73 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil Country Dynamics
  • Fig. 76 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Argentina Country Dynamics
  • Fig. 78 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 South Africa Country Dynamics
  • Fig. 81 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia Country Dynamics
  • Fig. 83 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 UAE Country Dynamics
  • Fig. 85 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Kuwait Country Dynamics
  • Fig. 87 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Market Position of Key Market Players